Imaging markers for bulbar involvement in inclusion body myositis among IBM and comparison groups
Official title: Advancing Bulbar Assessment in Inclusion Body Myositis Through a Multimodal Imaging Approach
Run by Johns Hopkins University · NCT07823101 · Data updated 2026-11-12
This study tests whether ultrasound and MRI can detect swallowing and bulbar muscle problems in people with inclusion body myositis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | November 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | October 28, 2026 |
| Trial ID | NCT07823101 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with a confirmed IBM diagnosis or related neuromuscular conditions, plus healthy controls.
✕Probably not a fit
Patients whose bulbar dysfunction does not correlate with imaging findings or who cannot complete the imaging procedures may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study uses neuromuscular ultrasound and MRI to identify imaging biomarkers of bulbar dysfunction in IBM. It compares imaging findings with those from other myopathies, ALS, PLS, and healthy controls during a one-time visit that may include neurological exams, swallowing questionnaires, tongue strength testing, and imaging. The goal is to find sensitive, objective markers that reflect dysphagia and bulbar involvement.
Why it matters
Potential benefit: If successful, participants may gain better understanding of bulbar involvement through imaging markers that could help guide future assessments.
How similar studies have gone: Previous work has explored imaging markers in neuromuscular diseases, but this study expands to IBM and includes comparative groups.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must have a confirmed diagnosis of inclusion body myositis (IBM), amyotrophic lateral sclerosis (ALS), primary lateral sclerosis (PLS), or myopathy in accordance with the respective diagnostic criteria. * Participants with disease must have clinically relevant laboratory testing for disease biomarkers (e.g., Creatine Kinase (CK), Comprehensive Metabolic Panel (CMP), Complete Blood Count (CBC)) within the last 12 months. * Participants must be able to remain supine for 30 minutes or longer and cannot have significant breathing difficulties. * Healthy controls must not have any neuromuscular disease. Exclusion Criteria: * Unable or unwilling to provide written informed consent. * Medical history or clinically significant physical examination or laboratory results that, in the opinion of the investigator, would render the participant unsuitable for the study. * Participants who are unlikely to comply with the study protocol or, in the opinion of the investigator, would not be a suitable candidate for participation in the study. * Patients with IBM, ALS, or myopathy who have another known neuromuscular condition with known bulbar involvement. * Any patient who has undergone a procedure for dysphagia, including myotomy, dilatation, or Botox.
Where it's running
-
The Johns Hopkins Hospital
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Abdullah Z AlQahtani, MD MPH — the Johns Hopkins School of Medicine
- Study coordinator: Joseph D Niang, B.A.
- Email: jniang1@jh.edu
- Phone: 410-570-3949
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Patient-rooted insights to shape myositis science
This global project asks people living with myositis (and their care partners) to share experiences and rank research questions so the community can see which issues matter most.
-
Measuring muscle health with a handheld electrical impedance device (mScan)
This project will test whether a handheld mScan device can quickly measure muscle health in adults with myopathies and in people without muscle disease by comparing its readings to MRI.
-
Tongue-strengthening exercises for people with ALS
This program will test whether daily tongue-strengthening exercises can help people with ALS maintain or improve speech and swallowing.
-
Natural history documentation of TNNT1 myopathy
This study is trying to learn more about how TNNT1 myopathy affects people over time to help improve future treatments.
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
7T MRI Pilot to Find Imaging Biomarkers in ALS and related motor neuron diseases
A 7T MRI study is being done to see if ultra-high-field brain scans can reveal non-invasive biomarkers in adults with motor neuron disease, including ALS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.